Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): rejected appeal

An appeal has been lodged for this appraisal, however it was rejected. Below are the papers related to this appeal.

For more information on the Technology Appraisal Appeal Process, go to the appeal hearings homepage.